Table 3.
CRISPR screens in other immune cells to enhance their anti-tumor reactivity
| Species | Target cells | Loss or gain of function | CRISPR library | Transduction methods | Selection methods | Genes identified | Corresponding proteins | Gene/protein functions | Years and references |
|---|---|---|---|---|---|---|---|---|---|
| Mouse | raw macrophage cell line 264.7 | loss of function | self-designed library with 7272 sgRNA targeting classical RBP genes | lentivirus transduction | TNF-α production | Mettl3 | METTL3 | METTL3-mediated m6A modification of Irakm mRNA accelerates its degradation, resulting in reprogramming macrophages for activation. | Tong et al. (2021)113 |
| cDC1s | loss of function | self-designed functional CRISPR library | retrovirus transduction | OVA cross-presentation | Wdfy4 | WDFY4 | Loss of function of BEACH domain–containing protein Wdfy4 substantially impaired cross-presentation of cell-associated antigens by cDC1s in mice. | Theisen et al. (2018)114 | |
| Human | IL-2 dependent NK cell line NK-92 | gain of function | self-designed library with 22 gRNAs using Benchling’s CRISPR Design tool | Cas RNP nucleofection | calcein-AM cytotoxic assay | FCGR3A | FCGR3A | Cas9-mediated promoter insertion effectively reactivated the endogenous FCGR3A and CD226 enhanced NK-92 cytotoxicity. | Huang et al. (2020)111 |
| CD226 | CD226 | ||||||||
| moDC | loss of function | Brunello | electroporation of in vitro-assembled Cas9-sgRNA complexes | loss of TNF-α secretion | TLR2 | TLR2 | TLR2 knockout caused decrease in TNF-α secretion. | Jost et al. (2021)115 | |
| PTPN6/SHP-1 | PTPN6 | PTPN6 knockout strongly increased TNF-α secretion and moderately decreased IL-10 secretion. | |||||||
| human myeloid cell line U937 | loss of function | self-designed 10-sgRNA-per-gene CRISPR-Cas9 deletion library | lentivirus transduction | phagocytosis ability | NHLRC2 | NHLRC2 | NHLRC2 negatively regulates RHOA, enabling RAC1-mediated cytoskeletal changes that are critical for phagocytosis. | Haney et al. (2018)116 | |
| ELOVL1 | ELOVL1 | ELOVL1 gene disruption causes significant decrease in phagocytosis. | |||||||
| TM2D3 | TM2D3 | TM2D2- and TM2D3-deficient cells show impaired clearance of amyloid-β aggregates. |
cDC1, classical dendritic cell; ELOVL1, elongation of very long chain fatty acids protein 1; FCGR3A, Fc gamma receptor IIIa; IL-2, interleukin-2; METTL3, methyltransferase 3; moDC, monocyte-derived dendritic cell; NHLRC2, NHL repeat containing protein 2; PTPN6, protein tyrosine phosphatase non-receptor type 6; TLR2, Toll-like receptor 2; TM2D3, TM2 domain containing 3; WDFY4, Wdfy family member 4.